Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. Cooley has 1000 lawyers across 15 offices in the United States, China and Europe. Cooley is counsel to more than 1400 public and private life sciences companies across the globe. We rank #1 for life sciences and healthcare venture over the last decade, #1 for issuer-side life sciences IPOs since 2000, Top 2 for biotech and pharma M&A in 2018 and have the largest life sciences IP team in the US. We have an unrivaled corporate partnering and licensing practice with a global transactions footprint and a unique and extensive understanding of biotech’s and pharma’s perspective, needs and deal drivers. We serve as counsel to more than 50% of the companies on the NASDAQ Biotechnology Index. Learn more at cooley.com.